William Mullen
Directeur/Bestuurslid bij NeuroTargets Ltd.
Profiel
William Mullen is a Non-Executive Director of NeuroTargets Ltd.
He was Chief Executive Officer of Progeny bioVentures Limited from 1996 to 1999.
He was Chief Executive Officer of Rowett Research Services Limited.
Dr. Mullen received a BS degree in Biochemistry from the University of Sussex and a PhD in Biochemistry from the University of Bath.
Actieve functies van William Mullen
| Bedrijven | Functie | Begin |
|---|---|---|
NeuroTargets Ltd.
 NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK. | Directeur/Bestuurslid | - |
Eerdere bekende functies van William Mullen
| Bedrijven | Functie | Einde |
|---|---|---|
Rowett Research Services Ltd.
 Rowett Research Services Ltd. Miscellaneous Commercial ServicesCommercial Services Rowett Research Services Ltd. provided biotechnology research services. The company was founded in 1988 and was headquartered in Aberdeen, the United Kingdom. | President | - |
Opleiding van William Mullen
| University of Bath | Doctorate Degree |
| University of Sussex | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
NeuroTargets Ltd.
NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK. | Health Technology |
Rowett Research Services Ltd.
Rowett Research Services Ltd. Miscellaneous Commercial ServicesCommercial Services Rowett Research Services Ltd. provided biotechnology research services. The company was founded in 1988 and was headquartered in Aberdeen, the United Kingdom. | Commercial Services |
